[327L-14] Reporting requirements. (a) Within thirty calendar days of writing a prescription, the attending provider shall submit a copy of the qualified patient's written request, as well as [a] copy of all the documentation required pursuant to section 327L-12 to the department.

(b) Within thirty calendar days following notification of the qualified patient's death from use of a prescribed medication pursuant to this chapter, or any other cause, the attending provider shall submit any follow-up information to the documentation required pursuant to section 327L-12 to the department.

(c) The department shall annually collect and review all information submitted pursuant to this chapter. The information collected shall be confidential and shall be collected in such a manner that protects the privacy of all qualified patients, the qualified patients' family, and any attending provider, consulting provider, or counselor involved with a qualified patient pursuant to this chapter. Information collected pursuant to this section by the department shall not be disclosed, discoverable, or compelled to be produced in any civil, criminal, administrative, or other proceeding.

(d) On or before July 1, 2019, and each year thereafter, the department shall create a report of information collected under subsection (c) and vital statistics records maintained by the department and shall post the report on the department's website. Information contained in the report shall only include:

(1) The number of qualified patients for whom a prescription was written pursuant to this chapter;

(2) The number of known qualified patients who died each year for whom a prescription was written pursuant to this chapter and the cause of death of those qualified patients;

(3) The total number of prescriptions written pursuant to this chapter for the year in which the report was created as well as cumulatively for all years beginning with 2019;

(4) The total number of qualified patients who died while enrolled in hospice or other similar palliative care program;

(5) The number of known deaths in Hawaii from a prescription written pursuant to this chapter per five-thousand deaths in Hawaii;

(6) The number of attending providers who wrote prescriptions pursuant to this chapter;

(7) Of the people who died as a result of self-administering a prescription pursuant to this chapter, the individual's:

(A) Age at death;

(B) Education level;

(C) Race;

(D) Sex;

(E) Type of insurance, if any; and

(F) Underlying illness; and

(8) Any other data deemed appropriate by the department. [L 2018, c 2, pt of 3]

 

 

Previous Vol06_Ch0321-0344 Next